Spotlight: Intec enrolls patients in PhIII trial

An MIT team has invented a device that makes a variety of drugs "on demand." "Think of this as the emergency backup for pharmaceutical manufacturing," MIT chemical engineering professor Allan Myerson said in a news release. "The purpose is not to replace traditional manufacturing; it's to provide an alternative for these special situations." More

> Intec Pharma enrolled its first patient in the Phase III trial of its drug delivering Accordion Pill for the treatment of Parkinson's Disease. More

> Sweden's Moberg Pharma has divested Jointflex, Fergon and Vanquish brands to Strides Pharma for $10.4 million. More

Whitepaper

Developing COVID-19 vaccines may not be enough: Turning vaccines into vaccinations

COVID-19 vaccines are being developed at a breakneck pace, but a broken supply chain could derail that momentum. What are the steps needed to help ensure the medical supply chain is up to the task?

Suggested Articles

RNA nanoparticles can squeeze into tumors and exit swiftly through the kidney, perfect for targeted delivery of cancer drugs, an OSU team says.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.